About
We focus on drug discovery and development for autoimmune disease and pain targets leveraging recombinant ion channel expression.
- Website
- Headquarters
- Industry
- Social
Org chart
View all (12)Doug Kahn
Chairman, CEO & President
Kevin O’Brien
CFO
Paul Colussi
SVP, Research
Ted Clark
CSO
Charlotte Mcdonagh
SVP, Development and Translational Science
Christopher Taron
Director
Marc R. Cote
Board Observer
Peter Kiener
Director
Robert Gailus
Director
Daniel Grau
Director
Ellen Baron
Director
Alison Taunton-Rigby
Director & Founder
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.